Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeff Sharman, MD
Willamette Valley Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
88 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tg Therapeutics Investigational Trial Site
Ashkelon, Israel
- Tg Therapeutics Investigational Trial Site
Huntsville, Alabama, United States
- Tg Therapeutics Investigational Trial Site
Mobile, Alabama, United States
- Tg Therapeutics Investigational Trial Site
Chandler, Arizona, United States
- Tg Therapeutics Investigational Trial Site
Tucson, Arizona, United States
- Tg Therapeutics Investigational Trial Site
Fayetteville, Arkansas, United States
- Tg Therapeutics Investigational Trial Site
Jonesboro, Arkansas, United States
- Tg Therapeutics Investigational Trial Site
Fullerton, California, United States
- Tg Therapeutics Investigational Trial Site
Greenbrae, California, United States
- Tg Therapeutics Investigational Trial Site
Los Angeles, California, United States
- Tg Therapeutics Investigational Trial Site
Pismo Beach, California, United States
- Tg Therapeutics Investigational Trial Site
Pleasanton, California, United States
- Tg Therapeutics Investigational Trial Site
Santa Barbara, California, United States
- Tg Therapeutics Investigational Trial Site
Aurora, Colorado, United States
- Tg Therapeutics Investigational Trial Site
Bridgeport, Connecticut, United States
- Tg Therapeutics Investigational Trial Site
Stamford, Connecticut, United States
- Tg Therapeutics Investigational Trial Site
Newark, Delaware, United States
- Tg Therapeutics Investigational Trial Site
Boca Raton, Florida, United States
- Tg Therapeutics Investigational Trial Site
Fort Myers, Florida, United States
- Tg Therapeutics Investigational Trial Site
Orange City, Florida, United States
- Tg Therapeutics Investigational Trial Site
Pensacola, Florida, United States
- Tg Therapeutics Investigational Trial Site
St. Petersburg, Florida, United States
- Tg Therapeutics Investigational Trial Site
West Palm Beach, Florida, United States
- Tg Therapeutics Investigational Trial Site
Albany, Georgia, United States
- Tg Therapeutics Investigational Trial Site
Newnan, Georgia, United States
- Tg Therapeutics Investigational Trial Site
Evanston, Illinois, United States
- Tg Therapeutics Investigational Trial Site
Maywood, Illinois, United States
- Tg Therapeutics Investigational Trial Site
Niles, Illinois, United States
- Tg Therapeutics Investigational Trial Site
Urbana, Illinois, United States
- Tg Therapeutics Investigational Trial Site
Fort Wayne, Indiana, United States
- Tg Therapeutics Investigational Trial Site
Indianapolis, Indiana, United States
- Tg Therapeutics Investigational Trial Site
Ames, Iowa, United States
- Tg Therapeutics Investigational Trial Site
Cedar Rapids, Iowa, United States
- Tg Therapeutics Investigational Trial Site
Westwood, Kansas, United States
- Tg Therapeutics Investigational Trial Site
Baton Rouge, Louisiana, United States
- Tg Therapeutics Investigational Trial Site
New Orleans, Louisiana, United States
- Tg Therapeutics Investigational Trial Site
Baltimore, Maryland, United States
- Tg Therapeutics Investigational Trial Site
Baltimore, Maryland, United States
- Tg Therapeutics Investigational Trial Site
Bethesda, Maryland, United States
- Tg Therapeutics Investigational Trial Site
Columbia, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jan 2015
- Primary completion
- 1 Apr 2020
- Completion
- 1 Apr 2020
- Last update posted
- 20 May 2022
- Registered enrollment
- 126
- Registry id
- NCT02301156
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.